Related Experiment Video
Updated: Jun 5, 2026
11:30
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
EULAR recommendations for calcium pyrophosphate deposition. Part II: management
W Zhang1, M Doherty, E Pascual
1Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK. weiya.zhang@nottingham.ac.uk
Annals of the Rheumatic Diseases
|January 25, 2011
Summary
Evidence-based guidelines for calcium pyrophosphate deposition (CPPD) management recommend a combination of non-pharmacological and pharmacological treatments for optimal care. Recommendations cover acute attacks, chronic symptoms, and prophylaxis, with varying strengths.
Area of Science:
- Rheumatology
- Crystal-induced Arthropathies
Background:
- Calcium pyrophosphate deposition (CPPD) disease, also known as pseudogout, is a crystal-induced arthropathy.
- Effective management strategies for CPPD are crucial for improving patient outcomes and quality of life.
Framework:
- A multidisciplinary European expert group developed key propositions for CPPD management using a Delphi consensus approach.
- Recommendations were informed by systematic literature reviews and assessed for strength using the European League Against Rheumatism visual analogue scale.
Implementation:
- Nine key recommendations address general management, acute attacks, prophylaxis, and chronic symptoms.
- Treatment options include non-pharmacological measures (e.g., joint aspiration, cool packs) and pharmacological agents (e.g., NSAIDs, colchicine, corticosteroids, methotrexate).
Implications:
- The developed guidelines provide a framework for evidence-based clinical practice in managing CPPD.
- These recommendations aim to standardize care and improve treatment efficacy for patients suffering from CPPD.
Related Concept Videos
01:30Urinary Tract Calculi III: Medical Management
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
01:28Urinary Tract Calculi V: Nursing Management
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...